TrialArthritis research & therapy2022

Efficacy and safety of HLX01 in patients with moderate-to-severe rheumatoid arthritis despite methotrexate therapy: a phase 3 study.

Xiaofeng Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.